Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ebos Group's Enterprise Value is A$4,931 Mil.
Ebos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$398 Mil. Therefore, Ebos Group's EV-to-EBIT ratio for today is 12.40.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ebos Group's Enterprise Value is A$4,931 Mil.
Ebos Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$557 Mil. Therefore, Ebos Group's EV-to-EBITDA ratio for today is 8.85.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ebos Group's Enterprise Value is A$4,931 Mil.
Ebos Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$12,938 Mil. Therefore, Ebos Group's EV-to-Revenue ratio for today is 0.38.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Ebos Group's Enterprise Value is A$4,931 Mil.
Ebos Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$231 Mil. Therefore, Ebos Group's EV-to-FCF ratio for today is 21.33.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Ebos Group (ASX:EBO) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Ebos Group's current Enterprise Value is A$4,931 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$398 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Ebos Group's current Enterprise Value is A$4,931 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was A$557 Mil.
Ebos Group's current Enterprise Value is A$4,931 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$12,938 Mil.
Ebos Group's current Enterprise Value is A$4,931 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$270 Mil.
Ebos Group's current Enterprise Value is A$4,931 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$231 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group Enterprise Value Related Terms
Ebos Group Enterprise Value Historical Data
* Premium members only.
The historical data trend for Ebos Group's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:EBO vs MCK, COR, CAH: Enterprise Value Comparison
For the Medical Distribution subindustry, Ebos Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Ebos Group's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Ebos Group's Enterprise Value for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a Enterprise Value of A$4,931 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ebos Group and its competitors.
Is Ebos Group's Enterprise Value too high?
Ebos Group's current Enterprise Value is A$4,931 Mil. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Enterprise Value compare to MCK and COR?
Ebos Group's Enterprise Value of A$4,931 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Ebos Group and its competitors. Ebos Group's current Enterprise Value is A$4,931 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$32.52, compared to a current price of A$16.76 — trading 48.5% below its estimated fair value. The current Enterprise Value is A$4,931 Mil. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Enterprise Value is A$4,931 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$16.76 is trading 48.5% below its estimated GF Value™ of A$32.52.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
Enterprise Value: A$4,931 Mil
GF Value™: A$32.52 vs. price of A$16.76 (48.5% below fair value)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
